Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Cytoplast Titanium-Reinforced PTFE Membranes

K-Number: K201187 · 2021-01-23

Decision Date2021-01-23
Product CodeNPK
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

Cytoplast Titanium-Reinforced PTFE Membranes is a medical device manufactured by Osteogenics Biomedical, Inc.. It received FDA 510(k) clearance on 2021-01-23 under approval number K201187. The device is classified under product code NPK. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Cytoplast Titanium-Reinforced PTFE Membranes?

Cytoplast Titanium-Reinforced PTFE Membranes is a medical device that received FDA 510(k) clearance on 2021-01-23. It is manufactured by Osteogenics Biomedical, Inc.. The 510(k) number is K201187.

When was Cytoplast Titanium-Reinforced PTFE Membranes approved by the FDA?

Cytoplast Titanium-Reinforced PTFE Membranes received FDA 510(k) clearance on 2021-01-23, under approval number K201187.

What company makes Cytoplast Titanium-Reinforced PTFE Membranes?

Cytoplast Titanium-Reinforced PTFE Membranes is manufactured by Osteogenics Biomedical, Inc..

What is the FDA product code for Cytoplast Titanium-Reinforced PTFE Membranes?

The FDA product code for Cytoplast Titanium-Reinforced PTFE Membranes is NPK.

Related Clinical Trials

Other Devices by Osteogenics Biomedical, Inc.

Related Devices (Code: NPK)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.